留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Graves病相关易感基因

穆龙龙 朱立

穆龙龙, 朱立. Graves病相关易感基因[J]. 协和医学杂志, 2011, 2(4): 375-379. doi: 10.3969/j.issn.1674-9081.2011.04.018
引用本文: 穆龙龙, 朱立. Graves病相关易感基因[J]. 协和医学杂志, 2011, 2(4): 375-379. doi: 10.3969/j.issn.1674-9081.2011.04.018

Graves病相关易感基因

doi: 10.3969/j.issn.1674-9081.2011.04.018
详细信息
    通讯作者:

    朱立 电话:010-65295516, E-mail:zhuli_xh@yahoo.com.cn

  • 中图分类号: R581.3;R34

  • [1] Vanderpump MPJ, Tunbridge WMG, French JM. The incidence of thyroid disorders in the community:a twenty-year follow-up of the Wickham survey[J]. Clin Endocrinol, 1995, 43:55-68. doi:  10.1111/j.1365-2265.1995.tb01894.x
    [2] Hsiao JY, Hsieh MC, Tien KJ, et al. Exon 33 T/T genotype of the thyroglobulin gene is a susceptibility gene for Graves' disease in Taiwanese and exon 12 C/C genotype protects against it[J]. Clin Exp Med, 2008, 8:17-21. doi:  10.1007/s10238-008-0151-5
    [3] Eschler DC, Hasham A, Tomer Y. Cutting edge:the etiology of autoimmune thyroid diseases[J]. Clin Rev Allergy Immunol, 2011, 41:190-197. doi:  10.1007/s12016-010-8245-8
    [4] Jozé lio Freire de Carvalho, Rosa Maria Rodrigues Pereira, Yehuda Shoenfeld. Pearls in autoimmunity[J]. Autoimmun Highlights, 2011, 2:1-4. doi:  10.1007/s13317-011-0016-x
    [5] Zanelli E, Breedveld FC, de Vries RR. HLA association with autoimmune disease:a failure to protect?[J]. Rheumatology (Oxford), 2000, 39:1060-1066. doi:  10.1093/rheumatology/39.10.1060
    [6] Kong YC, Brown NK, Flynn JC, et al. Efficacy of HLADRB1* 03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis[J]. J Autoimmun, 2011, 37:63-70. doi:  10.1016/j.jaut.2011.05.010
    [7] Ban Y, Davies TF, Greenberg DA, et al. Arginine at position 74 of the HLA-DRb1 chain is associated with Graves' disease[J]. Genes Immun, 2004, 5:203-208. doi:  10.1038/sj.gene.6364059
    [8] Yang J, Qin Q, Yan N, et al. CD40 C/T (-1) and CTLA-4 A/G (49) SNPs are associated with autoimmune thyroid diseases in the Chinese population[J/OL]. Endocrine, (2011-08-25)[2011-09-26] http://www.springer.com/?SGWID=0-102-24-0-0&searchType=EASY_CDA&queryText=CD40+C%2FT%28-1%29+and+CTLA-4+A%2FG%2849%29+SNPs+are+associated+with+autoimmune+thyroid+diseases+in+the+Chinese+population.
    [9] Resetkova E, Kawai K, Enomoto T, et al. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immuno deficient (SCID) mice[J]. Thyroid, 1996, 6:267-273. doi:  10.1089/thy.1996.6.267
    [10] Chen CR, Aliesky HA, Guo J, et al. Blockade of co-stimulation between T cells and antigen-presenting cells:an approach to suppress murine Graves' disease induced using thyrotropin receptor-expressing adenovirus[J]. Thyroid, 2006, 16:427-434. doi:  10.1089/thy.2006.16.427
    [11] Jacobson EM, Concepcion E, Oashi T, et al. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation:a case for translational pathophysiology[J]. Endocrinology, 2005, 146:2684-2691. doi:  10.1210/en.2004-1617
    [12] Anjos S, Nguyen A, Ounissi-Benkalha H, et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele[J]. J Biol Chem, 2002, 277:46478-46486. doi:  10.1074/jbc.M206894200
    [13] Ban Y, Davies TF, Greenberg DA, et al. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease[J]. Genes Immun, 2003, 4:586-593. doi:  10.1038/sj.gene.6364018
    [14] Takara M, Kouki T, DeGroot LJ. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease[J]. Thyroid, 2003, 13:1083-1089. doi:  10.1089/10507250360731479
    [15] Finn PW, He H, Wang Y, et al. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability[J]. J Immunol, 1997, 158:4074-4081. http://onlinelibrary.wiley.com/resolve/reference/PMED?id=9126965
    [16] Chu X, Pan CM, Zhao SX, et al. A genome-wide associa-tion study identifies two new risk loci for Graves' disease[J]. Nat Genet, 2011, 43:897-901. doi:  10.1038/ng.898
    [17] Gu LQ, Zhu W, Zhao SX, et al. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease[J]. Clin Endocrinol (Oxf), 2010, 72:248-255. doi:  10.1111/j.1365-2265.2009.03617.x
    [18] Collins JE, Heward JM, Carr-Smith J, et al. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease[J]. J Clin Endocrinol Metab, 2003, 88:5039-5042. doi:  10.1210/jc.2003-030093
    [19] Robinson JH, Delvig AA. Diversity in MHC class Ⅱ antigen presentation[J]. Immunology, 2002, 105:252-262. doi:  10.1046/j.0019-2805.2001.01358.x
    [20] Gebe JA, Swanson E, Kwok WW. HLA class Ⅱ peptidebinding and autoimmunity[J]. Tissue Antigens, 2002, 59:78-87. doi:  10.1034/j.1399-0039.2002.590202.x
    [21] Davies TF, Ando T, Lin RY, et al. Thyrotropin receptor-associated diseases:from adenomata to Graves disease[J]. J Clin Invest, 2005, 115:1972-1983. doi:  10.1172/JCI26031
    [22] Tonacchera M, Pinchera A. Thyrotropin receptor polymorphisms and thyroid diseases[J]. J Clin Endocrinol Metab, 2000, 85:2637-2639. doi:  10.1210/jcem.85.8.6801
    [23] Brand OJ, Gough SC. Genetics of thyroid autoimmunity and the role of the TSHR[J]. Mol Cell Endocrinol, 2010, 322:135-143. doi:  10.1016/j.mce.2010.01.013
    [24] D'Silva KJ, Zamora MB, Gerlach J, et al. Increased representation of the PTPN22 mutation in patients with immune thrombocytopenia[J]. J Thromb Haemost, 2010, 8:2076-2078. doi:  10.1111/j.1538-7836.2010.03954.x
    [25] Dechairo BM, Zabaneh D, Collins J, et al. Association of the TSHR gene with Graves' disease:the first disease specific locus[J]. Eur J Hum Genet, 2005, 13:1223-1230. doi:  10.1038/sj.ejhg.5201485
    [26] Bottini N, Vang T, Cucca F, et al. Role of PTPN22 in type 1 diabetes and other autoimmune diseases[J]. Semin Immunol, 2006, 18:207-213. doi:  10.1016/j.smim.2006.03.008
    [27] Ban Y, Tozaki T, Taniyama M, et al. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese[J]. Thyroid, 2005, 15:1115-1118. doi:  10.1089/thy.2005.15.1115
    [28] Brix TH, Kyvik KO, Christensen K, et al. Evidence for a major role of heredity in Graves' disease:a population-based study of two Danish twin cohorts[J]. J Clin Endocrinol Metab, 2001, 86:930-934. http://www.ncbi.nlm.nih.gov/pubmed/11158069
    [29] Tomer Y, Huber A. The etiology of autoimmune thyroid disease:a story of genes and environment[J]. J Autoimmun, 2009, 32:231-239. doi:  10.1016/j.jaut.2009.02.007
  • 加载中
计量
  • 文章访问数:  166
  • HTML全文浏览量:  54
  • PDF下载量:  3
  • 被引次数: 0
出版历程
  • 收稿日期:  2010-03-01
  • 刊出日期:  2011-10-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!